We reported previously that while B cells from healthy individuals can respond to pancreatic antigens, including GAD and IA2 when measured using an ELISpot assay, the B cells from people with type 1 diabetes have a significantly increased response [22]. This evidence concerns the gene GAD1 and type 1 diabetes mellitus.